Loncastuximab

(Synonyms: RB4v1.2)
2 Cited Publications
Kundenbewertung

Based on 2 publication(s) in Google Scholar

Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab has antitumor activity and can be used in the research of Non-Hodgkin Lymphoma (NHL) and Diffuse Large B-cell Lymphoma (DLBCL). Loncastuximab is capable of synthesizing the ADC molecule Loncastuximab tesirine (HY-P99349).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: ≥99.0%
  • CAS. Nr.: 1875032-68-0
  • Molecular Weight:144.46 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Loncastuximab

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00